Guided Therapeutics (GTHP) Market Capitalization (2021 - 2026)

Guided Therapeutics has disclosed Market Capitalization across 6 years of filings, most recently posting $23.2 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 169170.35% year-over-year to $23.2 million; the TTM figure through Jun 2026 stood at $23.2 million (up 169170.35% YoY), while the FY2025 annual figure was $17.6 million, up 260.0% from the prior year.
• Market Capitalization came in at $23.2 million for Q2 2026 at Guided Therapeutics, up from $12592.5 in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $23.2 million in Q2 2026 to a low of $5475.0 in Q1 2025.
• Average Market Capitalization over 5 years is $4.4 million, with a median of $11965.4 recorded in 2023.
• Year-over-year, Market Capitalization plunged 99.95% in 2023 and soared 169170.35% in 2026.
• Over 5 years, Market Capitalization stood at $9.8 million in 2022, then tumbled by 99.92% to $7394.6 in 2023, then rose by 11.06% to $8212.5 in 2024, then soared by 260.0% to $29565.0 in 2025, then surged by 78265.9% to $23.2 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $23.2 million in Q2 2026, $12592.5 in Q1 2026, and $29565.0 in Q4 2025.